arrow
E

Elena Di Gennaro

istituto nazionale tumori fondazione g. pascale
H指数:43
被引数:5,089

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer

miRquad:一种首创的dPCR多重TaqMan™高级临床研究检测试剂盒,用于头颈癌中的microRNA检测

2025-12-200
OAAI
Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer

丙戊酸通过β-连环蛋白调控靶向癌干细胞,提高奥沙利铂/氟嘧啶为基础的化疗在结直肠癌中的疗效

2025-08-010
OA
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy

液体活检中的代谢组学特征与接受免疫检查点抑制剂治疗的转移性黑色素瘤患者的总生存期相关

2025-04-100
OA
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol
2024-09-192
OAAI
Valproic acid combinEd with Simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic Pancreatic Adenocarcinoma patients-VESPA trial

丙戊酸联合辛伐他汀及吉西他滨/白蛋白结合型紫杉醇为基础方案在未经治疗的转移性胰腺腺癌患者中的研究——VESPA试验

2024-09-010
PRE
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study

Regorafenib单药治疗RAS突变型晚期结直肠癌 (STREAM) 患者的二线治疗: 一项学术,多中心,单臂,两阶段,II期研究

2023-02-012
OAAI
Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection

血浆代谢组学,脂质组学和细胞因子组学分析可预测接受肝切除术的转移性结直肠癌患者的疾病复发

2023-01-119
OAAI
Epilepsy Course and Developmental Trajectories in STXBP1-DEE
2022-06-0125
OAAI
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation (vol 41, 83, 2022)
2022-04-110
OAAI
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
2022-03-0326
OAAI
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer A Randomized Clinical Trial
2021-07-2621
OAAI
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations

意大利Lafora病队列: 临床特征,疾病演变和基因型-表型相关性

2021-05-0111
OAAI
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer

通过蛋白质组学方法鉴定的HSP90可作为逆转卵巢癌铂类耐药性的药物靶标

2021-01-1911
OAAI